Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes [Yahoo! Finance]
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Yahoo! Finance
The landmark study assessed the impact of AID (Automated Insulin Delivery) on a diverse group of people with type 2 diabetes who require insulin. The findings were shared at the American Diabetes Association 84th Scientific Sessions in Orlando, FL. Presently, Omnipod 5 is FDA-cleared in the United States and C.E. marked for use in those with type 1 diabetes aged two years and older. More on the Omnipod 5 Study The SECURE-T2D pivotal trial primarily aimed to evaluate change in HbA1c with Omnipod 5 in adults aged 18 to 75 years living with type 2 diabetes with a current insulin regimen for at least three months. Other criteria included a baseline HbA1c between 7% and 12% for those using basal insulin only and 12% or less for those using basal and bolus or pre-mixed insulin. Secondary objectives included demonstrating improvements in time in range and time in hyperglycemia, as well as demonstrating non-inferiority for hypoglycemia. Diabetes distress, a patient-reported outcome, was
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- ESLOY vs. PODD: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Insulet plans label expansion for Omnipod in type 2 diabetes [Yahoo! Finance]Yahoo! Finance
- Insulet's SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes [Yahoo! Finance]Yahoo! Finance
- Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 DiabetesBusiness Wire
- Insulet (PODD) Faces Increasing Competition [Yahoo! Finance]Yahoo! Finance
PODD
Earnings
- 5/9/24 - Beat
PODD
Sec Filings
- 6/25/24 - Form 144
- 6/17/24 - Form 4
- 6/14/24 - Form 144
- PODD's page on the SEC website